Stockholders Deficiency (Details Narrative) - USD ($)		1 Months Ended					12 Months Ended
	Dec. 12, 2018	Dec. 24, 2019	Mar. 31, 2019	Dec. 28, 2018	Feb. 26, 2018	Feb. 21, 2018	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2018	Aug. 13, 2019	Jul. 20, 2019	Jun. 25, 2019
Common stock, shares authorized							200,000,000	200,000,000	200,000,000
Stock options to purchase common stock										3,782,004
Accrued dividend payable							$ 11,846	$ 13,563	$ 13,563
Warrants to purchase commom shares											$ 377,500	$ 1,600,000
Fair value of option										$ 825,100
Exercise price										$ 0.75	$ 0.75	$ 0.75
Warrant modification expense							283,500
Stock-based compensation expense							844,128
Options							825,100
Warrants							14,631
Stock based benifit							$ 19,200
Common stock, shares issued							27,076,762	26,077,611	26,077,611	7,900,000
Stock based benifit description							A benefit of $19,200 (consisting of expense related to warrants of $3,300 and a benefit related to common stock of $22,500),
Stock-based compensation expense description							During the year ended December 31, 2019, $825,100 of stock-based compensation expense was included within research and development expenses and $19,028 was included within general and administrative expenses on the consolidated statement of operations.
Common stock, par value (in dollars per share)							$ 0.001	$ 0.001	$ 0.001
Preferred stock, shares authorized							10,000,000	10,000,000	10,000,000
Preferred stock, par value (in dollars per share)							$ 0.001	$ 0.001	$ 0.001
Shsres issued for servicies		7,500					160,083
Shares issued for servces, value		$ 1,876
Accrual of earned preferred stock dividends							$ 741,981		$ 451,283
Debt instrument, accrued interest and late payment penalties converted amount			$ 827,784
Common stock, value in connection with payment of Series A Convertible Preferred Stock dividends in-kind							$ 743,697
Issuance of Series A Convertible Preferred Stock in exchange for notes payable			145,367
Price per share							$ 0.75	0.75	$ 0.75
Issuance of Series A Convertible Preferred Stock in exchange for notes payable, value			$ 262,470
Issuance of Series A Convertible Preferred Stock for cash, net of offering expenses							239,425
Private placement memorandum description							The Board of Directors extended the expiration date of the Private Placement Memorandum (“PPM”), under which the Company continues to raise up to $10,000,000 via the sale of up to 1,333,333 shares of Series A Convertible Preferred Stock at $7.50 per share, on various dates in 2019
Loss on exchange of notes payable for equity							$ 1,504
Gain on exchange of accrued liabilities for warrants									$ 73,100
Warrant [Member]
Exercise price				$ 0.75	$ 0.75	$ 0.75
Shares reserved for future issuance				218,000	60,000	240,000
Value of shares reserved for future issuance				$ 35,900
Maturity period					5 years	5 years
Notes payable					$ 100,000	$ 400,000
Warrant [Member] | Members of Scientific Advisory Board [Member]
Accrued liabilities extinguished				109,000
Gain on exchange of accrued liabilities for warrants				$ 73,100
Series A Convertible Preferred Stock [Member]
Accrual of earned preferred stock dividends									$ 451,283
Common stock, value in connection with payment of Series A Convertible Preferred Stock dividends in-kind									$ 546,281
Price per share								$ 0.75	$ 0.75
Accrued preferred dividends								$ 13,563	$ 13,563
Common stock, shares issued in connection with payment of Series A Convertible Preferred Stock dividends in-kind									728,375
Series A Convertible Preferred Stock [Member] | Convertible Notes Payable [Member]
Loss on exchange of notes payable for equity	$ 191,251
Debt conversion converted amount, accrued interest	$ 382,500
Debt conversion converted instrument, shares issued	76,500
Debt conversion converted instrument, amount	$ 573,751
Series A Convertible Preferred Stock [Member] | January 1, 2018 [Member]
Accrued preferred dividends								$ 108,562	$ 108,562
Series A Convertible Preferred Stock [Member] | March 3, 2018 and November 6, 2018 [Member]
Price per share							$ 7.50
Proceeds from issuance of shares							$ 1,050,000
Sale of stock shares sold
Convertible Preferred Stock Series A [Member]
Price per share							$ 7.50
Preferred stock, shares designated							1,335,000
Proceeds from issuance of shares							$ 1,734,779
Gross proceeds from issuance of shares							1,795,677
Issuance costs							$ 68,898
Issuance costs description							issuance costs of $68,898 (which includes cash costs of $49,991 and accrued placement agent warrants with a fair value of $10,907 which are included in accrued compensation as of December 31, 2019),
Warrants and Common Stock [Member]
Stock based compensation expense (benefit)							$ 18,938		$ 18,938